Journal ArticleOPEN ACCESS

Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination

Emerging Infectious Diseases (2022) 28(6) 1274-1275
DOI: 10.3201/eid2806.220503
13Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

The SARS-CoV-2 Omicron variant BA.2 sublineage is rapidly replacing earlier Omicron lineages, suggesting BA.2 has increased vaccine evasion properties. We measured neutralization titers of authentic BA.1 and BA.2 isolates in serum samples from persons who received the BNT162b2 booster vaccine. All samples neutralized BA.1 and BA.2 at equal median values.

Cite

CITATION STYLE

APA

Pedersen, R. M., Bang, L. L., Madsen, L. W., Sydenham, T. V., Johansen, I. S., Jensen, T. G., … Andersen, T. E. (2022). Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination. Emerging Infectious Diseases, 28(6), 1274–1275. https://doi.org/10.3201/eid2806.220503

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free